651 related articles for article (PubMed ID: 9533549)
21. Survivin protein in UVB induced apoptosis of melanoma cells and in melanoma progression.
Zhang H
Oncol Rep; 2005 Jun; 13(6):1121-6. PubMed ID: 15870931
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
[TBL] [Abstract][Full Text] [Related]
23. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
Huijzer JC; McFarland M; Niles RM; Meadows GG
J Cell Physiol; 1996 Mar; 166(3):487-94. PubMed ID: 8600152
[TBL] [Abstract][Full Text] [Related]
24. Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells.
Meyer S; Hafner C; Guba M; Flegel S; Geissler EK; Becker B; Koehl GE; Orsó E; Landthaler M; Vogt T
Int J Oncol; 2005 Nov; 27(5):1197-206. PubMed ID: 16211213
[TBL] [Abstract][Full Text] [Related]
25. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.
Becker B; Multhoff G; Farkas B; Wild PJ; Landthaler M; Stolz W; Vogt T
Exp Dermatol; 2004 Jan; 13(1):27-32. PubMed ID: 15009113
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
27. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
28. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
[TBL] [Abstract][Full Text] [Related]
29. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.
Behrmann I; Wallner S; Komyod W; Heinrich PC; Schuierer M; Buettner R; Bosserhoff AK
Am J Pathol; 2003 Aug; 163(2):683-90. PubMed ID: 12875987
[TBL] [Abstract][Full Text] [Related]
30. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression.
de Vries TJ; Verheijen JH; de Bart AC; Weidle UH; Ruiter DJ; van Muijen GN
Cancer Res; 1996 Mar; 56(6):1432-9. PubMed ID: 8640836
[TBL] [Abstract][Full Text] [Related]
32. Human melanoma cells express functional receptors for thyroid-stimulating hormone.
Ellerhorst JA; Sendi-Naderi A; Johnson MK; Cooke CP; Dang SM; Diwan AH
Endocr Relat Cancer; 2006 Dec; 13(4):1269-77. PubMed ID: 17158770
[TBL] [Abstract][Full Text] [Related]
33. Melanoma metastasis is associated with enhanced expression of the syntenin gene.
Helmke BM; Polychronidis M; Benner A; Thome M; Arribas J; Deichmann M
Oncol Rep; 2004 Aug; 12(2):221-8. PubMed ID: 15254681
[TBL] [Abstract][Full Text] [Related]
34. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.
Gutman M; Singh RK; Radinsky R; Bar-Eli M
Anticancer Res; 1994; 14(5A):1759-65. PubMed ID: 7847808
[TBL] [Abstract][Full Text] [Related]
35. PAX4 has the potential to function as a tumor suppressor in human melanoma.
Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
[TBL] [Abstract][Full Text] [Related]
36. bcl-2 protein expression in melanocytic neoplasms of the skin.
Ramsay JA; From L; Kahn HJ
Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
[TBL] [Abstract][Full Text] [Related]
37. RNA fingerprinting displays UVB-specific disruption of transcriptional control in human melanocytes.
Vogt TM; Welsh J; Stolz W; Kullmann F; Jung B; Landthaler M; McClelland M
Cancer Res; 1997 Aug; 57(16):3554-61. PubMed ID: 9270028
[TBL] [Abstract][Full Text] [Related]
38. The genes encoding the eph-related receptor tyrosine kinase ligands LERK-1 (EPLG1, Epl1), LERK-3 (EPLG3, Epl3), and LERK-4 (EPLG4, Epl4) are clustered on human chromosome 1 and mouse chromosome 3.
Cerretti DP; Lyman SD; Kozlosky CJ; Copeland NG; Gilbert DJ; Jenkins NA; Valentine V; Kirstein MN; Shapiro DN; Morris SW
Genomics; 1996 Apr; 33(2):277-82. PubMed ID: 8660976
[TBL] [Abstract][Full Text] [Related]
39. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
40. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]